
A New Registry Study for a Rare Form of Breast Cancer
Working under the hypothesis that a subset of de novo oligometastatic breast cancer patients who are treated with a combination of systemic therapy, surgery, and radiation or ablation of metastatic sites will have long-term distant metastasis free and overall survival, this multi-cohort, prospective, nationwide registry study will enroll newly diagnosed oligometastatic (operationally defined by local tumor boards as disease where all metastatic lesions can be ablated) HER2+ breast cancer patients. Using an online portal, physicians can download a consent form, register patients, receive a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.